Sabby Management, LLC Vaxcyte, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.32 - $26.45 $1.28 Million - $1.76 Million	-66,483 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.26 - $26.97 $1.04 Million - $1.39 Million	-51,511 Reduced 43.66%	66,483 $1.69 Million
Q2 2021 Aug 16, 2021	SELL	$16.45 - $24.06 $1 Million - $1.47 Million	-60,998 Reduced 34.08%	117,994 $2.66 Million
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $3.34 Million - $5.22 Million	178,992 New	178,992 $3.54 Million

350

130M

539K

253K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.43B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.